La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CaixaBank Bilan de santé

Santé financière contrôle des critères 4/6

CaixaBank possède un actif total de €630.4B et un capital total de €35.5B. Le total des dépôts est €445.1B et le total des prêts est €365.9B générant une marge d'intérêt nette de 1.9%. La provision pour créances douteuses est insuffisante, puisqu'elle représente actuellement 2.6% du total des prêts. Les liquidités et les placements à court terme représentent €12.0B.

Informations clés

17.8x

Ratio actifs/fonds propres

1.9%

Marge d'intérêt nette

Total des dépôts	€445.13b
Ratio prêts/dépôts	Approprié
Prêts irrécouvrables	2.6%
Provision pour créances douteuses	Faible
Ratio de liquidité générale	Faible
Trésorerie et équivalents	€12.00b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

CaixaBank (BME:CABK) Is Increasing Its Dividend To €0.1868

Apr 06

Should Shareholders Reconsider CaixaBank, S.A.'s (BME:CABK) CEO Compensation Package?

May 06

News Flash: Analysts Just Made A Captivating Upgrade To Their CaixaBank, S.A. (BME:CABK) Forecasts

Apr 01

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Niveau d'actif: Le ratio actifs/capitaux propres de CABK ( 17.8 x) est modéré.

Provision pour créances douteuses: CABK a une faible provision pour créances douteuses ( 72 %).

Passifs à faible risque: 75% du passif de CABK est constitué principalement de sources de financement à faible risque.

Niveau de prêt: CABK a un niveau approprié de ratio prêts/actifs ( 58% ).

Dépôts à faible risque: Le ratio prêts/dépôts de CABK ( 82% ) est approprié.

Niveau des créances douteuses: CABK a un niveau élevé de créances douteuses ( 2.6 %).

CaixaBank Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

New minor risk - Share price stability

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues in line with analyst expectations

Criteria in Talks with Potential Investor in Energy Group Naturgy

Dividend of €0.32 announced

Fosun International Reportedly Open to Sale of Stake in Millennium

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

CaixaBank, S.A., Annual General Meeting, Mar 22, 2024

CaixaBank, S.A., Annual General Meeting, Mar 21, 2024

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

CaixaBank, S.A. to Report Q4, 2023 Results on Feb 02, 2024

CaixaBank, S.A. to Report Q4, 2023 Results on Feb 02, 2024

New major risk - Revenue and earnings growth

Sandton Capital Partners LP agreed to acquire a 50.99% stake in Sistemas Técnicos de Encofrados, S.A. from Banco Santander, S.A. (BME:SAN), CaixaBank, S.A. (BME:CABK) and Banco de Sabadell, S.A. (BME:SAB).

Sandton Capital Partners LP agreed to acquire a 50.99% stake in Sistemas Técnicos de Encofrados, S.A. from Banco Santander, S.A. (BME:SAN), CaixaBank, S.A. (BME:CABK) and Banco de Sabadell, S.A. (BME:SAB).

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

CaixaBank (BME:CABK) Is Increasing Its Dividend To €0.1868

Now 21% undervalued

CaixaBank, S.A., Annual General Meeting, Mar 31, 2023

Full year 2022 earnings: Revenues exceed analyst expectations

Now 20% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Now 21% undervalued

Now 22% undervalued

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of €0.12 per share

Investor sentiment improved over the past week

Now 22% undervalued

CaixaBank, S.A., Annual General Meeting, Apr 08, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: EPS exceeds analyst expectations

Third quarter 2021 earnings released: EPS €0.087 (vs €0.087 in 3Q 2020)

Caixabank Announces Plan to Cut More Jobs

Consensus forecasts updated

Upcoming dividend of €0.022 per share

Should Shareholders Reconsider CaixaBank, S.A.'s (BME:CABK) CEO Compensation Package?

Consensus forecasts updated

Consensus revenue estimates increase to €10.6b

Price target increased to €2.77

News Flash: Analysts Just Made A Captivating Upgrade To Their CaixaBank, S.A. (BME:CABK) Forecasts

Analysts increase EPS estimates to €0.28

New 90-day high: €2.41

How Many CaixaBank, S.A. (BME:CABK) Shares Did Insiders Buy, In The Last Year?

Full year 2020 earnings released: EPS €0.23 (vs €0.26 in FY 2019)

Revenue and earnings beat expectations

Analysts update estimates

How Many CaixaBank, S.A. (BME:CABK) Shares Do Institutions Own?

New 90-day high: €2.34

CaixaBank, S.A. (BME:CABK) Is An Attractive Dividend Stock - Here's Why

New 90-day high: €2.29

Caixabank and Bankia Announce Board Appointments

A Look At CaixaBank's (BME:CABK) Share Price Returns

New 90-day high: €2.17

Market bids up stock over the past week

Analysts update estimates

Third quarter earnings released

Third-quarter earnings released: Earnings beat expectations

New 90-day low: €1.62

New 90-day low: €1.74

CaixaBank, S.A. (BME:CABK) entered into a plan of merger to acquire Bankia, S.A. (BME:BKIA) from BFA Tenedora de Acciones S.A.U. and others for €4.3 billion.

Spanish Banks Bankia and Caixabank in Merger Talks

New 90-day low - €1.78

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Découvrir des entreprises saines